Prevention of Frey's Syndrome with the Use of Porcine Dermal Collagen Graft: Retrospective Analysis of 76 "Formal" Parotidectomies for Benign Pathologies.


Journal

The Annals of otology, rhinology, and laryngology
ISSN: 1943-572X
Titre abrégé: Ann Otol Rhinol Laryngol
Pays: United States
ID NLM: 0407300

Informations de publication

Date de publication:
Sep 2021
Historique:
pubmed: 9 2 2021
medline: 27 7 2021
entrez: 8 2 2021
Statut: ppublish

Résumé

Frey's syndrome is a well-known complication of parotid surgery; its prevention may be achieved by the use of an interpositional barrier between the overlying flaps and the exposed parenchymal bed of parotid gland. The aim of this study was to retrospectively evaluate clinical outcomes with and without the interpositional placement of a porcine dermal collagen graft (PDCG) for prevention of syndrome occurrence. We conducted a 20-year retrospective study including the patients who had undergone "formal" (superficial, total, or subtotal) parotidectomies for benign pathologies. The inclusion criteria also involved patients that were (i) regularly monitored about clinical symptoms related to syndrome, and (ii) examined with Minor starch-iodine test. The severity of the diagnosed syndrome was retrospectively evaluated according to the grading score system of Luna-Ortiz. To assess group differences in terms of the extent of dissection in operating sites, we estimated the tumor and histological specimen volumes using the available dimensions. We included Porcine dermal collagen is a safe, practical, and useful means for parotid reconstruction, since it seems to contribute in prevention of Frey's syndrome when increased amount of glandular tissue has to be removed. Additional randomized controlled studies with bigger samples are required to better assess the PDCG use in parotid surgery.

Sections du résumé

BACKGROUND BACKGROUND
Frey's syndrome is a well-known complication of parotid surgery; its prevention may be achieved by the use of an interpositional barrier between the overlying flaps and the exposed parenchymal bed of parotid gland. The aim of this study was to retrospectively evaluate clinical outcomes with and without the interpositional placement of a porcine dermal collagen graft (PDCG) for prevention of syndrome occurrence.
METHODS METHODS
We conducted a 20-year retrospective study including the patients who had undergone "formal" (superficial, total, or subtotal) parotidectomies for benign pathologies. The inclusion criteria also involved patients that were (i) regularly monitored about clinical symptoms related to syndrome, and (ii) examined with Minor starch-iodine test. The severity of the diagnosed syndrome was retrospectively evaluated according to the grading score system of Luna-Ortiz. To assess group differences in terms of the extent of dissection in operating sites, we estimated the tumor and histological specimen volumes using the available dimensions.
RESULTS RESULTS
We included
CONCLUSION CONCLUSIONS
Porcine dermal collagen is a safe, practical, and useful means for parotid reconstruction, since it seems to contribute in prevention of Frey's syndrome when increased amount of glandular tissue has to be removed. Additional randomized controlled studies with bigger samples are required to better assess the PDCG use in parotid surgery.

Identifiants

pubmed: 33554618
doi: 10.1177/0003489421990185
doi:

Substances chimiques

Permacol 0
Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1036-1043

Auteurs

Kostas Vahtsevanos (K)

Department of Oral and Maxillofacial Surgery, Theagenio Cancer Hospital, Thessaloniki, Greece.

Angelos Chatziavramidis (A)

ENT Department, Theagenio Cancer Hospital, Thessaloniki, Greece.

Ioannis Yiannis Papadiochos (IY)

Clinic of Maxillofacial Surgery and Stomatology, CHU d'Amiens-Picardie Site Sud, France.

Georgios Koloutsos (G)

Department of Oral and Maxillofacial Surgery, Theagenio Cancer Hospital, Thessaloniki, Greece.

Anastasios Stefanidis (A)

ENT Department, Theagenio Cancer Hospital, Thessaloniki, Greece.

Kyriaki Kitikidou (K)

Department of Forestry and Management of the Environment and Natural Resources, Laboratory of Forest Biometry, Dimokritos University of Thrace, Orestias, Greece.

Aris Ntomouchtsis (A)

Department of Oral and Maxillofacial Surgery, Theagenio Cancer Hospital, Thessaloniki, Greece.

Anna Patrikidou (A)

Drug Development Unit, Sarah Cannon Research Institute and University London College Hospitals & UCL Cancer Institute, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH